KEGG   DRUG: Fluticasone furoate, umeclidinium bromide and vilanterol
Entry
D11035            Mixture   Drug                                   
Name
Fluticasone furoate, umeclidinium bromide and vilanterol;
Trelegy ellipta (TN)
Product
TRELEGY ELLIPTA (GlaxoSmithKline LLC)
Component
Fluticasone furoate [DR:D06315], Umeclidinium bromide [DR:D10181], (Vilanterol trifenatate [DR:D09697] | Vilanterol [DR:D09696])
Remark
Therapeutic category: 2290
ATC code: R03AL08
Product: D11035<JP/US>
Efficacy
Bronchodilator
  Disease
Chronic obstructive pulmonary disease [DS:H01714]
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 R RESPIRATORY SYSTEM
  R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
   R03A ADRENERGICS, INHALANTS
    R03AL Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids
     R03AL08 Vilanterol, umeclidinium bromide and fluticasone furoate
      D11035  Fluticasone furoate, umeclidinium bromide and vilanterol <JP/US>
USP drug classification [BR:br08302]
 Respiratory Tract/Pulmonary Agents
  Bronchodilator Combinations
   Fluticasone Furoate/ Umeclidinium/ Vilanterol
    D11035  Fluticasone furoate, umeclidinium bromide and vilanterol
Therapeutic category of drugs in Japan [BR:br08301]
 2  Agents affecting individual organs
  22  Respiratory organ agents
   229  Miscellaneous
    2290  Miscellaneous
     D11035  Fluticasone furoate, umeclidinium bromide and vilanterol
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D11035
Other DBs
PubChem: 350078354
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system